Immunotherapy for Triple-Negative Breast Cancer

Immunotherapy for Triple-Negative Breast Cancer

Panelists Adam M. Brufsky, MD, PhD; Carlos L. Arteaga, MD; Debu Tripathy, MD; José Baselga, MD, PhD; Kimberly L. Blackwell, MD; and Denise A. Yardley, MD, review the evidence to date for using immunotherapy for breast cancer, preliminary data for immunoconjugates and checkpoint inhibitors, and potential predictive biomarkers.